Search In this Thesis
   Search In this Thesis  
العنوان
Recent Combined Modality in
Treatment of Pancreatic
Adenocarcinoma /
المؤلف
El-Ghazawy,Hagar Ibrahim.
هيئة الاعداد
باحث / Hagar Ibrahim El-Ghazawy
مشرف / Atef Yossef Ryad
مشرف / Hesham Mahmoud Al Wakeel
مشرف / Mohamed Yassin Mostafa
تاريخ النشر
2012
عدد الصفحات
256p.:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الأشعة والطب النووي والتصوير
تاريخ الإجازة
1/1/2012
مكان الإجازة
جامعة عين شمس - كلية الطب - الطب النووى و الاورام
الفهرس
Only 14 pages are availabe for public view

from 256

from 256

Abstract

Pancreatic cancer has a relatively high incidence, making
it one of the top ten incidence cancers and rank the fourth
among cancer related death.
Patients with pancreatic cancer are best cared for by
multidisciplinary teams that include surgeons, medical and
radiation oncologists, radiologists, nutritionists and pain
specialists.
Resection remains the only chance for a cure of
pancreatic adenocarcinoma, and resectable patients should
undergo surgery, followed by adjuvant therapy.
Borderline resectable patients can receive neoadjuvant
therapy in the hope of undergoing surgery and higher chance of
negative margin.
Patients with locally advanced unresectable disease and
good performance status can undergo chemotherapy and
chemoradiation.Good performance status patients presenting with
metastatic disease can receive palliative chemotherapy and also,
any other palliative measures should be considered.
Early introduction of supportive/ palliative care might
provide patients with better physical and emotional symptom
control and better quality of life.